All In Biotech

Drug Trial Radar · NCT00299689

Phase II Trial of Ontak With Metastatic Melanoma

Phase II Trial of ONTAK With Metastatic Melanoma

Last checked: Nov 20, 2026Latest source record: Sep 5, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

69

Actual

Start

Mar 2006

Primary completion

Jan 2010

Study completion Jan 2010

Sponsor

Lead sponsor
James Graham Brown Cancer CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Louisville
First posted
Mar 7, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether ONTAK is an effective treatment in patients with Stage IV Melanoma

Conditions

  • Malignant Melanoma

Interventions

  • Denileukin diftitoxDrug

    12 mcg/kg IV (in vein) over 30 minutes on days 1 through 4 of each 21 day cycle for 4 cycles.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Positive Response Defined as Clinical Complete Response, Partial Response or Stable Disease (Persisting for at Least 4 Weeks) as Measure by Modified RECIST CriteriaTime frame: 2 weeks after completion of second cycle

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • James Graham Brown Cancer Center, Univ. of Louisville

    Louisville, Kentucky

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.